Healthbeat - Your Source for Daily Health Trends and Medical News

‘The crux of all evil’: what happened to the first city that tried to ban smartphones for under-14s?

It’s a year since teachers in St Albans asked parents not to give younger children smartphones.

‘Concerning’ lack of female-only medical trials in UK, say health experts

Exclusive: doctors and patients forced to make decisions in ‘vacuum of evidence’ as women under-represented in dataHealth experts are calling for more UK clinical trials to focus on finding new tr

First-in-Human OCT-FLIm Structural-Molecular Imaging for High-Risk Plaque

This diagnostic feasibility study tests whether a novel dual-modal intracoronary imaging technique is a clinically feasible and safe diagnostic tool for identifying high-risk plaques in patients with

Calprotectin and Atherosclerotic Cardiovascular Disease

This population-based cohort study examines the prospective association between circulating calprotectin and atherosclerotic cardiovascular disease as well as the mechanistic contributions of calprote

Taking Time for a Second Opinion About Breast Cancer Treatment

(MedPage Today) -- Taking time to get a second opinion on breast cancer treatment did not significantly alter the time to treatment, which still occurred within the currently recommended timeframe, a

Philip Sunshine, 94, Dies; Physician Who Pioneered Treatment of Premature Babies

A founder of neonatology, he helped revolutionize the care of preterm and critically ill newborns. “We were able to keep babies alive that would not have survived,” he said.

Trial Helps Unravel Migraine-Depression Knot

(MedPage Today) -- Fremanezumab (Ajovy) reduced depression symptoms and monthly migraine attacks in people with episodic or chronic migraine and major depressive disorder, the phase IV UNITE trial sh

H5N1 Bird Flu Cases Have Slowed in Animals and People

(MedPage Today) -- Detections of H5N1 avian influenza have slowed in both animals and humans, but continued surveillance is warranted, CDC researchers said.

Vinay Prasad, Critic of COVID Measures, Picked as FDA's Top Vaccine Official

(MedPage Today) -- Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research

STAT+: Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA

Vinay Prasad, tapped to be a top official at the FDA, has never shied from speaking his mind.

All News